OBJECTIVE: To perform voxel-wise assessments of regional brain atrophy state and rate in subjects with relapsing-remitting (RR) multiple sclerosis (MS). BACKGROUND: Recently, attention has focused on defining the tissue compartments and regions within which brain atrophy occurs. These regional measures of brain volume changes may help to better define the nature of the pathology underlying MS. In this context, specific regional measures of grey matter (GM) volume changes can be obtained by using the voxel-based morphometry (VBM) approach. METHODS: Fifty-nine subjects with RR MS underwent conventional MRI at baseline and after a mean follow-up period of 3 years. Cross-sectionally, two VBM analyses (SPM-VBM, based on the Statistical Parametri...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
OBJECTIVE: To explore the potential usefulness of two new magnetic resonance imaging (MRI) analysis ...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
OBJECTIVE: To perform voxel-wise assessments of regional brain atrophy state and rate in subjects wi...
OBJECTIVE: To investigate the in-vivo correlates of brain atrophy in patients with multiple sclerosi...
We performed voxel-guided morphometry (VGM) investigating the mechanisms of brain atrophy in multipl...
BACKGROUND: In multiple sclerosis (MS) regional grey matter (GM) atrophy has been associated with di...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
BACKGROUND AND PURPOSE: Progressive brain atrophy is a well-known feature of multiple sclerosis (MS)...
OBJECTIVE: To assess the time course of brain atrophy and the difference across clinical subtypes in...
BACKGROUND: Regional atrophy measures may offer useful information about the causes of specific clin...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
INTRODUCTION: Multiple sclerosis (MS) is characterized, besides focal lesions, by brain atrophy. Th...
Introduction: In multiple sclerosis (MS), brain atrophy measurement on magnetic resonance imaging (M...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
OBJECTIVE: To explore the potential usefulness of two new magnetic resonance imaging (MRI) analysis ...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...
OBJECTIVE: To perform voxel-wise assessments of regional brain atrophy state and rate in subjects wi...
OBJECTIVE: To investigate the in-vivo correlates of brain atrophy in patients with multiple sclerosi...
We performed voxel-guided morphometry (VGM) investigating the mechanisms of brain atrophy in multipl...
BACKGROUND: In multiple sclerosis (MS) regional grey matter (GM) atrophy has been associated with di...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
BACKGROUND AND PURPOSE: Progressive brain atrophy is a well-known feature of multiple sclerosis (MS)...
OBJECTIVE: To assess the time course of brain atrophy and the difference across clinical subtypes in...
BACKGROUND: Regional atrophy measures may offer useful information about the causes of specific clin...
OBJECTIVE: To determine whether brain atrophy and lesion volumes predict subsequent 10 year clinica...
INTRODUCTION: Multiple sclerosis (MS) is characterized, besides focal lesions, by brain atrophy. Th...
Introduction: In multiple sclerosis (MS), brain atrophy measurement on magnetic resonance imaging (M...
Background: In multiple sclerosis (MS), demyelination and neuro-axonal loss occur in the brain ...
OBJECTIVE: To explore the potential usefulness of two new magnetic resonance imaging (MRI) analysis ...
OBJECTIVE: To determine the relation of gray matter (GM) and white matter (WM) brain volumes, and WM...